The GLP-1 Gold Rush: Will Trump Rewrite the Rules for Eli Lilly and Novo Nordisk?

The Billion-Dollar Battle for the Future of Weight Loss: Pfizer Jumps into the Ring

The Great Weight-Loss Gambit: Pfizer Jumps into the Billion-Dollar Battle for Obesity Treatment Supremacy

The Great GLP-1 Gold Rush: Pfizer Jumps into the Billion-Dollar Battle for Weight Loss Dominance

The Great Weight-Loss Race: Pfizer's Billion-Dollar Gambit to Conquer Obesity

The Lilly Lull: Why a Minor Dip Might Be Just a Blip in a Pharmaceutical Powerhouse's Journey

The Great Prescription Price Shake-Up: Could Trump's Bold Plan Reshape US Healthcare?

The Price of Progress? Unpacking the Billion-Dollar Buzz Around America's New Weight-Loss Fixes

The GLP-1 Gambit: Pharma Giants, Trump, and the High Stakes of Drug Prices

The Great Negotiation: Big Pharma, Weight Loss, and the White House

The Grand Alliance: Eli Lilly, NVIDIA, and the Supercomputer Set to Reshape Medicine

A New Horizon in the Battle Against Alzheimer's: Hope Arrives, But Not Without Hurdles

A Cruel Twist of Fate: Alzheimer's Hope Dawns, But Not for Everyone — Yet.

A Breath of Relief: How Eli Lilly's Omvoh is Tackling Ulcerative Colitis Urgency Head-On

The Week That Was: Big Moves, Bold Bets, and Shifting Sands in the Corporate World

A Breakthrough Moment: Unpacking Olumiant's Promise for Young Lives Touched by Alopecia

The Revolving Door: Ex-FDA Regulators Find New Homes at Pharma Giants Like Eli Lilly

FDA Greenlights Groundbreaking Blood Test for Alzheimer's Disease

A New Dawn for Diagnostics: FDA Approves First Blood Test for Alzheimer's Disease

A New Dawn for Alzheimer's Diagnosis: FDA Approves Roche and Eli Lilly's Groundbreaking Blood Test

UK's Controversial Drug Price Hike: Pharma Giants Hit the Brakes on Investment

A New Chapter: Peter Marks, Former FDA Vaccine Czar, Lands at Eli Lilly

A Billion-Dollar Bet: Eli Lilly's Monumental Investment Ignites India's Pharma Future

Eli Lilly Unveils $1 Billion India Investment to Supercharge Mounjaro Production

Telangana's Trillion-Dollar Leap: Eli Lilly Injects $1 Billion, Reshaping India's Pharma Future

The Great Pharma Debate: Which Giant Will Dominate Your Portfolio?

The Future of Fat Loss: Novo Nordisk Unleashes Its Next-Gen Weapon in the High-Stakes Drug Wars

The Mind Behind Miracles: Daniel Skovronsky's Blueprint for Eli Lilly's R&D Revolution

The GLP-1 Gold Rush: Why Morgan Stanley Just Downgraded Novo Nordisk Amid Fierce Competition

Global Markets Rebound: Asian Shares Climb After Wall Street Ends Downturn

Unmasking the Hidden Health Crisis: Why 'Thin-Fat' Indians Redefine Obesity and the Promise of GLP-1 Drugs

Eli Lilly's Groundbreaking Oral Weight-Loss Pill Set to Transform India's Obesity Battle

Eli Lilly Declares UK 'Worst in Europe' for Drug Prices, Threatening Patient Access to New Medicines

Celltrion Fortifies Biologics Dominance with Strategic Eli Lilly Plant Acquisition

South Korean Pharma Giant Celltrion Seals $330M Deal for Eli Lilly's U.S. Biologics Facility

The Race for the Next Weight Loss Breakthrough: Chinese Biotechs Challenge Global Giants

Game-Changer: New Ozempic-Like Pill Achieves Remarkable 13% Weight Loss in Landmark Study

Pfizer's Bold Gambit: Unlocking the Future of Obesity Treatment with Metsera and Oral GLP-1s

Orforglipron: The Oral Weight-Loss Revolution – Promise or Peril?